跳至主要内容
临床试验/EUCTR2009-014176-22-IT
EUCTR2009-014176-22-IT进行中(未招募)不适用

A comparison of prasugrel at the time of percutaneous coronary intervention (PCI) or as pretreatment at the time of diagnosis in patients with NOn-ST-elevation myocardial infarction(NSTEMI): the ACCOAST study - ACCOAST Study

Eli Lilly & Company0 个研究点目标入组 4,100 人开始时间: 2009年11月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
4,100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Subjects aged 18 years and above presenting with NSTEMI with elevated troponin (≥1.5 times the upper limit of normal [ULN]) who are scheduled for coronary angiography/PCI ≥2 and <24 hours from planned randomization. If necessary due to timing constraints, coronary angiography/PCI may be scheduled the next day with the intention to perform coronary angiography/PCI within 24 hours but definitely no later than 48 hours from randomization.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • STEMI Cardiogenic shock at time of randomization refractory ventricular arrhytmias congestive heart failure cardiac arrest prior TIA or stroke Active pathological bleeding Severe hepatic impairment

研究者

发起方
Eli Lilly & Company

相似试验

进行中(未招募)
1 期
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADFAcute Coronary SyndromesMedDRA version: 14.0Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014176-22-SKEli Lilly4,100
进行中(未招募)
不适用
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI): The ACCOAST Study - ACCOASTAcute Coronary SyndromesMedDRA version: 14.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014176-22-PLEli Lilly and Company4,100
进行中(未招募)
不适用
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADF
EUCTR2009-014176-22-DKEli Lilly4,100
进行中(未招募)
1 期
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADFAcute Coronary SyndromesMedDRA version: 13.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014176-22-BEEli Lilly4,100
进行中(未招募)
不适用
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADFAcute Coronary SyndromesMedDRA version: 14.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014176-22-FIEli Lilly4,100